Details der Publikation - Randomizované kontrolované klinické hodnocení vlivu aliskirenu na prevenci závažných kardiovaskulárních príhod u starších osob

Randomizované kontrolované klinické hodnocení vlivu aliskirenu na prevenci závažných kardiovaskulárních príhod u starších osob : A Randomized Controlled Trial of Aliskiren in the Prevention of Major Cardiovascular Events in Elderly People Aliskiren Prevention Of Later Life Outcomes (APOLLO) - APOLLO

Medienart:	Klinische Studie

Erscheinungsjahr:	2016
Erschienen:	2016

Enthalten in:	WHO International Clinical Trials Registry Platform - (2016) vom: 14. Nov. Zur Gesamtaufnahme - year:2016

Sprache:	Tschechisch

Links:	Volltext [kostenfrei]

Themen:	610 Medical Condition: cardiovacular disease,functional hypertension, MedDRA version: 14.0Level: PTClassification code 10020772Term: HypertensionSystem Organ Class: 10047065 - Vascular disorders MedDRA version: 14.0Level: LLTClassification code 10007648Term: Cardiovascular disease, unspecifiedSystem Organ Class: 10007541 - Cardiac disorders;Therapeutic area: Diseases [C] - Cardiovascular Diseases [C14] Phase: Phase 3 Recruitment Status: Not yet recruiting Study Type: Interventional

Anmerkungen:	WHO International Clinical Trials Registry Platform (https://www.who.int/ictrp/en/), First posted: 19-10-2010, Last updated: 2022-11-24

ICTRP ID:	EUCTR2009-010170-38-CZ CSPP100G2301 2009-010170-38-SE

Förderinstitution / Projekttitel:

PPN (Katalog-ID):	CTG005805740

Internformat


LEADER	01000caa a22002652 4500
001	CTG005805740
003	DE-627
005	20230425165323.0
007	cr uuu---uuuuu
008	210507s2016 xx \|\|\|\|\|o 00\| \|\|cze c
035			\|a (DE-627)CTG005805740
035			\|a (UBBS_Klinische_Studien_WHO)EUCTR2009-010170-38-CZ
035			\|a (UBBS_Klinische_Studien_WHO)CSPP100G2301
035			\|a (UBBS_Klinische_Studien_WHO)2009-010170-38-SE
040			\|a DE-627 \|b ger \|c DE-627 \|e rakwb
041			\|a cze
245	1	0	\|a Randomizované kontrolované klinické hodnocení vlivu aliskirenu na prevenci závažných kardiovaskulárních príhod u starších osob \|b A Randomized Controlled Trial of Aliskiren in the Prevention of Major Cardiovascular Events in Elderly People Aliskiren Prevention Of Later Life Outcomes (APOLLO) - APOLLO
264		1	\|c 2016
336			\|a Text \|b txt \|2 rdacontent
337			\|a Computermedien \|b c \|2 rdamedia
338			\|a Online-Ressource \|b cr \|2 rdacarrier
500			\|a WHO International Clinical Trials Registry Platform (https://www.who.int/ictrp/en/), First posted: 19-10-2010, Last updated: 2022-11-24
650		4	\|a Medical Condition: cardiovacular disease,functional hypertension, MedDRA version: 14.0Level: PTClassification code 10020772Term: HypertensionSystem Organ Class: 10047065 - Vascular disorders MedDRA version: 14.0Level: LLTClassification code 10007648Term: Cardiovascular disease, unspecifiedSystem Organ Class: 10007541 - Cardiac disorders;Therapeutic area: Diseases [C] - Cardiovascular Diseases [C14]
650		4	\|a Study Type: Interventional
650		4	\|a Phase: Phase 3
650		4	\|a Recruitment Status: Not yet recruiting
650		4	\|a 610
773	0	8	\|i Enthalten in \|t WHO International Clinical Trials Registry Platform \|g (2016) vom: 14. Nov.
773	1	8	\|g year:2016 \|g day:14 \|g month:11
856	4	0	\|u https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2009-010170-38 \|z kostenfrei \|3 Volltext
912			\|a GBV_CTG
912			\|a SSG-OLC-PHA
951			\|a AR
952			\|j 2016 \|b 14 \|c 11

Zugang & Verfügbarkeit

Zugehörige Publikationen/Bände